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Abstract
Biallelic genetic mutations in the Park2 and PINK1 genes are frequent causes of autosomal
recessive PD. Carriers of single heterozygous mutations may manifest subtle signs of dis-
ease, thus providing a unique model of preclinical PD. One emerging hypothesis suggests
that non-motor symptom of PD, such as cognitive impairment may be due to a distributed
functional disruption of various neuronal circuits. Using resting-state functional MRI (RS-
fMRI), we tested the hypothesis that abnormal connectivity within and between brain net-
works may account for the patients’ cognitive status. Eight homozygous and 12 heterozy-
gous carriers of either PINK1 or Park2 mutation and 22 healthy controls underwent RS-
fMRI and cognitive assessment. RS-fMRI data underwent independent component analy-
sis to identify five networks of interest: default-mode network, salience network, executive
network, right and left fronto-parietal networks. Functional connectivity within and between
each network was assessed and compared between groups. All mutation carriers were
cognitively impaired, with the homozygous group reporting a more prominent impairment in
visuo-spatial working memory. Changes in functional connectivity were evident within all
networks between homozygous carriers and controls. Also heterozygotes reported areas
of reduced connectivity when compared to controls within two networks. Additionally,
increased inter-network connectivity was observed in both groups of mutation carriers,
which correlated with their spatial working memory performance, and could thus be inter-
preted as compensatory. We conclude that both homozygous and heterozygous carriers
exhibit pathophysiological changes unveiled by RS-fMRI, which can account for the pres-
ence/severity of cognitive symptoms.
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Introduction
Parkinson’s disease (PD) is the secondmost common neurodegenerative disorder after Alzhei-
mer’s disease in the population aged over 65 years. The core features of PD include resting-
tremor, rigidity, bradykinesia and postural instability, but non-motor symptoms such as cogni-
tive decline, neuropsychiatric disorders and dysautonomia are also frequently observed [1]. Rel-
evant for clinical management, cognitive deficits can be present in PD since the early clinical
stages, including frontal-executive dysfunction, difficultieswith set-shifting, visuospatial deficits,
and impairments in learning and memory [2]. In recent years, researchers have put increasing
efforts to clarify the pathophysiology of cognitive impairment in PD and, to this aim, the avail-
ability of a conditionmimicking preclinical stages in humans is of great interest. Relevant prog-
ress in this field has come from studies of mendelian forms of parkinsonism, in particular those
recessively inherited. Biallelic mutations in three genes (Park2/Parkin, PINK1, and less fre-
quently DJ-1) are mainly responsible for a fully penetrant, autosomal recessive PD phenotype
(ARPD). ARPD is clinically characterized by early onset, slow progression, excellent response to
levodopa, and variable occurrence of additional features such as dystonia at onset, sleep benefit,
hyperreflexia and psychiatric symptoms [3]. Interestingly, single heterozygous mutations in
Park2 and PINK1 genes can be identified in patients with features indistinguishable from spo-
radic, late-onset PD, as well as in non-symptomatic individuals [4]. These mutations are
regarded as minor susceptibility factors modulating the risk for developing PD in a multifacto-
rial context. Moreover, there is growing evidence indicating that even non-symptomatic hetero-
zygous carriers (i.e., relatives of patients with biallelic mutations) often present with subtle signs
of dopaminergic dysfunction, as demonstrated by Photon Emission Tomography and func-
tional MR imaging (fMRI) [5,6]. These individuals provide therefore a uniquemodel for in vivo
research into the pre-clinical stages of PD. Additionally, it was shown that carriers of single
mutations in PINK1 or Park2 genes show a similar phenotype at a brain network level [7],
which is consistent with the closely related dysfunctional effect of gene disruption in several in
vitro and in vivomodels [8]. To date, a few studies investigating the cognitive profile of individu-
als with ARPD have been published. Three of them have consistently reported that Park2-
mutated patients perform similarly or even better than non-mutated patients on cognitive test-
ing [9,10]. On the other hand, other studies have described cognitive impairment in patients
with Park2 mutations [11], as well as non-specific cognitive deficits in healthy heterozygous car-
riers [10]. We recently published neuropsychological data from PINK1 homozygous and hetero-
zygous mutation carriers followed-up for 12 years, based on the Montreal CognitiveAssessment
battery (MoCA) and an extensive battery exploring all principal cognitive domains [12]. Inter-
estingly, all affected homozygotes and 5 out of 14 heterozygotes reported abnormal scores at the
MoCA and at tests sensitive to frontal dysfunction, consistently with the dysexecutive syndrome
which is typically observed in sporadic PD [13]. The pathophysiological basis of these non-
motor manifestations cannot be completely attributed to dysfunction of the basal ganglia, and
may be the consequence of distributed functional disruption in various neuronal circuits [14].
Against this background, functional imaging studies may provide relevant insights, especially in
the absence of macroscopic brain abnormalities. Resting-state fMRI (RS-fMRI) has gained par-
ticular value for the investigation of cognitive symptoms in neurodegenerative diseases. This
non-invasive MRI technique relies on the neural spontaneous blood-oxygen-level dependent
(BOLD) signal fluctuations to estimate the intrinsic activity synchronization across the entire
brain at rest, without requiring any experimental task [15]. So far, distinct RS-fMRI networks
have been identified in healthy subjects [15], and selective disruptions in their functional con-
nectivity (FC) have been observed in various neurodegenerative disorders including sporadic
PD [16]. In particular, the default-mode network (DMN), whose disruption has been associated
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to impairment of global cognition [17], was recently investigated in patients with PD, showing
reduced FC in the medial temporal lobe and in the inferior parietal cortex [18]. Other networks
are also likely to be implicated in PD, and might exhibit distinct patterns of abnormalities at dif-
ferent disease stages. For instance, in a genetic variant of frontotemporal dementia, FC was
shown to play in distinct networks either a pathogenetic or a compensatory role when assessed
at preclinical or clinical stages of disease [19].
A key question in PD is to determine whether different RS-fMRI networks interact with
each other in determining higher level functions and dysfunctions across disease evolution
(i.e., inter-network connectivity) [20]. The current study aims at investigating the role of
dynamic changes across five major networks of interest (i.e., DMN, salience network [SN],
executive network [ExN], right and left fronto-parietal networks [rFP] and [lFP]) in determin-
ing the cognitive status of individuals with different mutational loads in subjects with ARPD-
causative genes. To this purpose, we recruited homozygous (HOM) and heterozygous (HET)
carriers of either PINK1 or Park2 mutations. In the frame of this experimentalmodel, we
attempted to clarify the pathophysiology of cognitive impairment in PD whenmoving from
preclinical, or very early (HET individuals) to overt disease stages (HOM individuals). From a
clinical/neuropsychological viewpoint, our prediction was to identify visuospatial memory def-
icits, which are typical of PD, in HOM individuals. Conversely, in HET individuals, we
expected to identify preclinical FC modifications in the absence of obvious neuropsychological
deficits.
Materials and Methods
Participants
Eight HOM patients (5 PINK1 and 3 Park2 mutation carriers; M/F = 6/3; mean age = 51.4,
SD = 8.1 years), 12 HET relatives (10 PINK1 and 2 Park2 mutation carriers; M/F = 5/10;
mean age = 40.2, SD = 14.7 years) and 22 age- and gender-matched healthy controls (HC;
M/F = 10/12; mean age = 47.0, SD = 12.3 years) took part in the study (see Table 1 for demo-
graphic, clinical and pharmacological characteristics). The diagnosis of clinically definite or
probable PD was made according to the clinical diagnostic criteria of the UK PD Society
Brain Bank [21], with the only exception that positive family history was not considered as
an exclusion criterion. Disease severity was estimated by the Hoehn & Yahr stages and the
Unified PD Rating Scale [22, 23]. Major systemic, psychiatric, and other neurological ill-
nesses were carefully investigated and excluded in all subjects. Local Ethical Committee
approved the project and written informed consent was obtained by all participants before
study initiation.
Neuropsychological assessment
Cognitive assessment was performed by two trained neuropsychologists on the same day of
MRI acquisition. The MoCA [24] and the Frontal Assessment Battery (FAB) [25] were admin-
istered to all subjects. Additionally, mutation carriers underwent the following battery of tests:
1) Verbal episodic long-termmemory: Immediate and Delayed recall of a 15-Word List [26];
Short Story Recall [27]; 2) Visuo-spatial episodic long-termmemory:Delayed recall of Com-
plex Rey’s Figure [28]; 3) short-termmemory:Digit-span and Corsi Block Tapping task [29];
4) Executive functions: PhonologicalWord Fluency [26]; CategoricalWord Fluency [27]; Trail
Making Test [30]; Stroop test [31]; 4) Problem-solving: Raven’s Colored Progressive Matrices
[26]; Praxis: Copy of drawings [27]; Copy of Complex Rey’s Figure [28]. For each test, appro-
priate adjustments for gender, age, and education were applied according to the Italian
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normative data. In addition, available cut-off scores of normality (95% of the lowest tolerance
limit of the normal population distribution) were applied.
Subjects were considered as “cognitively impaired” if they reported pathological scores at
MoCA [3]. Scores obtained at other tests were used to assess group differences betweenHOM
and HET individuals and for correlations with imaging data. In the former case, a series of t-
tests for independent samples were used (statistical threshold = p<0.003 after Bonferroni’s
correction).
MRI
All subjects underwentMRI at 3T (Magnetom Allegra, Siemens, Erlangen, Germany), includ-
ing the following acquisitions: 1) Dual-echo turbo spin-echo (TSE) (TR = 6.190 ms, TE = 12/
109 ms); 2) fast-FLAIR (TR = 8.170 ms, TE = 96 ms, TI = 2.100 ms); 3) 3DModified-Driven-
Equilibrium-Fourier-Transform (MDEFT) scan (TR = 1338 ms, TE = 2.4 ms,
Matrix = 256x224x176, FOV = 250x250 mm2, slice thickness = 1 mm); 4) T2weighted echo-
planar image (EPI) sensitized to BOLD contrast (TR = 2080 ms, TE = 30 ms, 32 axial slices par-
allel to AC-PC line, matrix: 64x64, pixel size = 3x3 mm2, slice thickness = 2.5 mm, flip-
angle = 70°) for RS-fMRI. BOLD EPIs were collected during rest for 7 min and 20s, resulting in
a total of 220 volumes.
Image analysis
Dual-echoTSE and FLAIR images were reviewed by a neurologist expert in MRI to assess/
exclude the presence of macroscopic abnormalities.
For each subject the first four volumes of the RS-fMRI series were discarded to allow for T1
equilibration effects. Statistical parametric mapping (SPM8; www.fil.ion.ucl.ac.uk\spm) was
used for image preprocessing and statistical comparison of RS-fMRI data. The preprocessing
steps included correction for head motion (using the standard realignment algorithm in
SPM8), compensation for slice-dependent time shifts, and co-registrationwith the correspond-
ing MDEFT. The MDEFT was segmented using the segmentation algorithm in SPM8, and the
resulting grey matter (GM) images were used to compute every subject’s total GM volume. The
Table 1. Principal demographic and clinical characteristics of studied subjects. Abbreviations: HET = heterozygous; HOM = homozygous;
HC = healthy controls; SD = standard deviation; LEDD = Levodopa equivalent daily dose; UPDRS = Unified Parkinson’s Disease Rating Scale;
MOCA = Montreal Cognitive Assessment; H&Y = Hoehn and Yahr scale.
HC (n = 22) HET (n = 12) HOM (n = 8)
Age at scan (SD) 47.0 (12.2) 41.9 (14.8) 51.4 (8.1)
Sex (M/F) 10/12 5/7 6/2
Educational level (SD) 14.7 (3.2) 12.3 (2.1) 11.4 (2.3)*
MOCA / 23.8 (1.8) ˚ 23.0 (2.6) ˚
Diagnosis / 10 unaffected/ 2 possibly affected Affected
Disease duration / / 18.2 (8.5)
Pink/Parkin / 10/2 5/3
LEDD / / 590.9 (358.1)
UPDRS / 1.7 (3.7) 23.2 (19.9)#
H&Y / / 2.2 (0.9)
* HC vs. HOM/HET p< 0.05
˚ pathological score
# HOM vs. HET p< 0.05.
doi:10.1371/journal.pone.0163980.t001
Resting State fMRI in Autosomal Recessive PD
PLOS ONE | DOI:10.1371/journal.pone.0163980 October 27, 2016 4 / 16
segmentation also provides the normalization parameters that map the subject’s brain into
Montreal Neurological Institute coordinates. The same parameters were applied to the motion
and slice-timing corrected EPI images. Then, they were filtered by a phase-insensitive band-
pass (0.01–0.08 Hz) to reduce the effect of low frequency drift and high frequency physiological
noise. Finally, smoothing with a 3D-Gaussian Kernel of 8 mm3 FWHMwas applied. Group
Independent Component Analysis (ICA) fMRI Toolbox (GIFT, www.icatb.sourceforge.net)
was used for component decomposition and set to identify 20 independent components.
Results were converted to Z-scores. The components were reviewed to identify the DMN, the
SN, the ExN, the lFP and the rFP networks [15].
Intra-network analysis
To statistically evaluate intra-network FC of each selected network, second level analyses were
implemented in SPM8 on participants’ reconstructed spatial maps. First, we performed a
cross-sectional analysis (with a full-factorial design) with the group of HC, HET and HOM as
main factor and GM volume and years of education as covariates of no interest, for each single
network separately. Then, a correlation analysis was performed using a two sample T-test, with
group belonging (HOM or HET) as factor, the Corsi score as covariate of interest, and the total
GM volume and type of genetic mutation (PINK1/Park2) as covariates of no interest. Results
were accepted as significant at p<0.05 FWE cluster-level corrected.
Inter-network analysis
To statistically evaluate inter-network FC, subject specific network time courses were
detrended and pairwise correlated by Pearson's correlation, following an established procedure
[32,33]. Briefly, we computed the constrainedmaximal lagged correlation between all pair-wise
combinations of networks. Correlation coefficients and corresponding p values in each pair of
networks were calculated for different lags (ranging from -12 to 12), where lags were circularly
shifted. The best p value (corresponding to the optimal lag between two networks) was used in
the subsequent analysis. To assess between-group differences, correlation coefficientswere
transformed to z-scores using the Fisher's z-transformation and entered into a between-subject
ANOVA with education and total GM volumes as variables of no interest (p<0.05, Bonfer-
roni-corrected).
Finally, in order to investigate the association between inter-network connectivity and
severity of cognitive symptoms, we correlated the internetwork z-scores of each pair of net-
works with cognitive scores, with the total GM volume as covariate of no interest.
Results
Clinical and neuropsychological evaluation
There was a statistically significant difference in the average number of years of education
betweenHC and HOM, but not betweenHET and either HOM or HC. The years of education
were subsequently introduced as a covariate of no interest in all fMRI analyses. All other demo-
graphic features were matched across groups (Table 1).
All HOM patients had a diagnosis of clinically definite PD, as confirmed by the Unified PD
Rating Scale (Table 1). In the HET group, two PINK1 carriers received a diagnosis of possible
PD (subjects F1-IV:13/M and F1-IV:12/M, already reported in a previous publication) [12].
With respect to cognitive assessment (Table 2), all but two PD individuals (one from the
HOM, one from the HET group; carriers of PINK1mutation in both cases) reported pathologi-
cal scores at MoCA, and were classified as cognitively impaired. Interestingly, all Park2
Resting State fMRI in Autosomal Recessive PD
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mutation carriers (3 HOM and 2 HET) showed cognitive impairment. When comparing HOM
and HET subjects for their performance in single cognitive domains, the former group resulted
significantlymore impaired in visuo-spatial working memory.
Intra-network RS-fMRI
All RS networks of interest were detectable from ICA decomposition. As expected, the DMN
included the posterior and anterior cingulate cortex and the right and left inferior parietal
nodes; the rFP and lFP networks included the right/left anterior insula, the medial prefrontal
cortex, and the right/left frontal and parietal regions; the ExN included the dorsolateral prefron-
tal and the posterior parietal cortex; the SN included the hippocampus, parahippocampal gyrus,
retrosplenial cortex, posterior cingulate cortex, precuneus, temporo-parietal junction, angular
gyrus, lateral temporal cortex, ventrolateral prefrontal cortex, and medial prefrontal cortex.
Between-group comparisons of intra-network connectivity are shown in Table 3 and Fig 1.
Within the DMN, both HET and HOM subjects showed lower FC than HC in the precu-
neus.Within the ExN, HOM patients showed decreased connectivity than HC in the frontal
pole bilaterally (a similar finding was detectable, at uncorrected level, also in HOM patients
compared to HET individuals).Within the rFP network, HOM patients showed decreased FC
in the right angular/supramarginal gyruswhen compared to HC, and in the right superior
frontal gyruswhen compared to HET individuals.
Table 3. Changes in FC in five networks of interest. Brain areas of significant FC alteration in RS-net-
works (A) and of significant correlation between Corsi score and FC (B) HOM ARPD.
MNI coordinates
Brain area Size R/L x y z T-value p value
(A)
Default mode network
HC > HET
Posterior cuyngulate gyrus/Precuneus 558 L -2 -52 28 5.01 0.002
HC > HOM
Precuneus 413 L -4 -64 36 5.15 0.01
Executive network
HC > HOM
Frontal pole 517 R 26 48 26 4.82 0.002
Frontal pole 298 L -26 46 26 4.25 0.05
Right working memory network
HC > HOM
Angular gyrus/Supramarginal gyrus 472 R 62 -60 20 4.40 0.005
HET > HOM
Superior frontal gyrus 456 R 20 26 58 4.38 0.05
(B)
Right working memory network
Superior frontal gyrus 731 R 18 32 44 8.63 0.000
Left working memory network
Middle frontal gyrus 224 L -32 4 48 9.12 0.03
Salience netwrork
Paracyngulate gyrus 297 L -10 38 28 6.09 0.031
Executive network
Ant cingulate gyrus 266 R 4 0 34 5.35 0.005
doi:10.1371/journal.pone.0163980.t003
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Positive correlations were found between the Corsi scores reported by HOM, but not by
HET individuals, and their FC in various networks (Fig 2). Within the rFP, this pattern of cor-
relation was found in the right superior frontal gyrus;within the lFP it was found in the left
middle frontal gyrus; in the SN it was localized in the left paracingulate gyrus; and finally, in
the ExN, it was localized to the anterior cingulate gyrus.
Fig 1. Between group FC changes within the RS-fMRI networks of interest. This figure illustrates
between-group differences in functional brain connectivity observed in individual networks: A) the default
mode network (DMN), B) the executive network (ExN), and C) the right fronto-parietal network (rFP). In all
cases, the networks (main effect of groups) are shown in yellow. Red areas show the regional pattern of
reduced connectivity in homozygous mutation carriers (HOM) as compared to healthy controls (HC). Blue
areas show the regional pattern of reduced connectivity in heterozygous mutation carriers (HET) as
compared to HC. Pink areas show the regional pattern of reduced connectivity in HOM as compared to HET.
For each contrast, the signal plots on the right show the group level of connectivity at the peak of some
clusters.
doi:10.1371/journal.pone.0163980.g001
Resting State fMRI in Autosomal Recessive PD
PLOS ONE | DOI:10.1371/journal.pone.0163980 October 27, 2016 8 / 16
Inter-network RS-fMRI
The inter-network FC correlation was evaluated for ten pairs of networks (resulting from all
pair-wise combinations of 5 networks). Table 4 summarizes the optimal lag, r, and p vales of
correlation for each pair of networks in each group (HC, HET, HOM).
Three significant differences in the z-values (expressing the strength of between-network
correlation in FC) for patients versus controls and between the two genetic groups (HOM and
HET) were identified using an ANOVA model with “group” as factor. As shown in Fig 3A,
these group differences in inter-network connectivity were found between SN-rFP (F(1,42) =
3.87, p<0.01), DMN-rFP (F(1,42) = 4.10, p<0.01) and SN-DMN (F(1,42) = 3.88, p<0.01). In
the case of SN-rFP, the difference was driven by an increased inter-network connectivity in the
HOM group compared to both, HC (t(42) = 3.12, p<0.01) and HET individuals (t(42) = 3.04,
p<0.01), while no significant difference was found betweenHC and HET individuals (t(42)<
1). In the case of DMN-rFP, the significantmain effect was driven by reduced inter-network
FC correlation in HOM as compared to HET (t(42) = 2.47, p< 0.05) and an increased
Fig 2. Associations between single network FC and spatial working memory performance in HOM patients.
Within each network (shown in yellow), red areas illustrate the brain regions whose functional connectivity was
positively associated with scores reported by homozygous (HOM) mutation carriers at the Corsi test (spatial
working memory). These regions included: the left middle frontal gyrus within the left fronto-parietal network (A); the
right superior frontal gyrus within the right fronto-parietal network (B); the left paracingulate gyrus within the salience
network (C); and the right anterior cingulate gyrus within the executive network (D).
doi:10.1371/journal.pone.0163980.g002
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connectivity in HET as compared to HC (t(42) = 2.00, p< 0.058). Finally, the difference in the
SN-DMN was driven by an increase of inter-network FC in the group of HET compared to
both HC (t (42) = 2.12, p< 0.05) and HOM (t(42) = 2.37, p< 0.05), whereas no difference was
found betweenHC and HOM individuals (t(42)<1).
The inter-network connectivity z scores were correlated with the performance at Corsi test.
In the SN-rFP pair, z scores were negatively correlated with the Corsi scores across the two
genetic groups (HOM, HET), indicating that an increase in the connectivity between these two
networks (mainly present in the HOM group) was associated with a worse performance in
visuo-spatial working memory.
The inter-network connectivity scores in the SN-DMN and DMN-SN pairs of networks cor-
related positively with the Corsi score (r = 0.49, p<0.04 and r = 0.48, p<0.04 respectively). An
increased connectivity, mainly present in HET individuals, was associated with a better perfor-
mance in visuo-spatial working memory, indicating possible compensating mechanisms.
These correlations are shown in Fig 3B.
Table 4. Inter-network correlation results. Mean lag, Pearson r index and p values of the inter-network
FC correlations in the group of healthy controls (HC), HET individuals and HOM patients.
lag r p
DMN_ExN HC -0.136 -0.451 0.029
HET 0.214 -0.434 0.001
HOM -0.375 -0.355 0.031
DMN_lFP HC -0.273 -0.387 0.001
HET -2.286 0.319 0.016
HOM 1.250 -0.351 0.005
DMN_rFP HC -0.682 -0.305 0.006
HET -0.643 0.332 0.002
HOM 0.375 -0.476 0.000
DMN_SN HC -1.136 -0.370 0.006
HET -0.571 0.359 0.003
HOM 1.000 -0.391 0.000
lFP_ExN HC -0.136 0.357 0.009
HET -0.429 -0.329 0.011
HOM 0.750 0.269 0.059
lFP_rFP HC 0.318 0.387 0.005
HET -0.643 0.458 0.000
HOM 0.250 0.491 0.001
rFP_ExN HC 1.500 0.311 0.027
HET -0.571 -0.364 0.004
HOM 1.625 0.329 0.011
SN_ExN HC -0.591 0.384 0.005
HET 0.000 0.395 0.001
HOM 0.750 0.401 0.019
SN_lFP HC -0.318 0.392 0.011
HET -1.500 -0.273 0.058
HOM 0.000 0.320 0.016
SN_rFP HC -0.273 0.335 0.005
HET -0.143 0.299 0.011
HOM -0.250 0.526 0.001
doi:10.1371/journal.pone.0163980.t004
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Levodopa treatment is known to potentially affect functional brain connectivity [34], and
therefore constitutes a potential bias in this study, as only the HOM group is under treatment.
To estimate the magnitude of this effect, we tested for correlations between individual levodopa
equivalent daily dose (LEDD) and FC in all networks of interest in HOM patients (the only
group under medication).Within the limitation of our small sample size we were unable to
detect any significant association between LEDD and FC.
Discussion
In this study, we recruited subjects carrying single or biallelic mutations in either PINK1 or
Park2 which, theoretically, may be regarded as a model for preclinical and clinical stages of PD.
Mutations in these two genes have been shown to result in a similar phenotype at a brain net-
work level [7], allowing individuals with PINK1 and Park2 mutations to be included in the
same experimental setting.
Consistently, all HOM patients responded to a diagnosis of clinically definite PD, while 10
out of 12 subjects from the HET group were classified as clinically unaffected. The focus of this
study was to identify, using RS-fMRI, the pathophysiological substrates for the cognitive status
Fig 3. Inter-network analysis. Panel A shows the mean (SD) internetwork z scores for each studied group (i.e.,
healthy controls, HC; homozygous (HOM) and heterozygous (HET) mutation carriers) in three pairs of networks:
salience network and right fronto-temporal network (SN-rFP); default mode network and right fronto-temporal
network (DMN—rFP); salience network and default mode network (SN-DMN). Asterisks highlight significant
between-group differences. Panel B illustrates the significant correlations, obtained in HOM (green-square marks)
and HET (red-rhomb marks) mutation carriers altogether, between mean internetwork z scores in SN-rFP and
SN-DMN pairs of networks and individual scores obtained at Corsi test (spatial working memory span).
doi:10.1371/journal.pone.0163980.g003
Resting State fMRI in Autosomal Recessive PD
PLOS ONE | DOI:10.1371/journal.pone.0163980 October 27, 2016 11 / 16
of HET and HOM individuals. In sporadic PD, cognitive impairment has been shown to occur
since early clinical stages, probably following a long non-symptomatic period of brain compen-
sation. This means that, in our experimentalmodel, HET individuals were expected to be less
cognitively impaired than HOM patients. However, consistent with a previous study on PINK1
mutation carriers (including part of the patients enrolled here) [12], all but one subjects from
either group (HET, HOM) reported pathological scores at MoCA. Moreover, the two cogni-
tively preserved individuals were both PINK1 heterozygous carriers, while all Park2 mutation
carriers (3 HET, 2 HOM) showed pathological scores at MoCA. This is the first study reporting
such a finding in Park2 mutated subjects, which is apparently in contrast with previous reports
[9, 10]. Nevertheless, as previously suggested,MoCA is highly sensitive in detecting cognitive
deficits in PD [33], and this might account for inconsistences across studies. Additionally, the
similar cognitive profile we observed in PINK1 and Park2 mutation carriers is congruent with
recent neuroimaging studies, suggesting a similar endophenotype for the two genes [7]. After
characterizing the cognitive profile of all recruited subjects, we focused on the patterns of FC,
in order to explore potential substrates for their neuropsychological characteristics.We focused
our analysis on five specific networks that, according to previous literature [16, 18, 35–37],
have proven to be meaningful in reflecting brain connectivity abnormalities in PD. We first
analyzed each network in isolation (intra-network connectivity), and then we explored their
interaction (inter-network connectivity) as a function of disease severity. When considering
the DMN in isolation, both genetic groups (HOM and HET) compared to controls revealed
reduced connectivity in the posterior cingulate cortex, with no significant differences between
them. This finding fits well with the pathological scores reported by this genetic cohort at
MoCA (i.e., a measure of global cognition) irrespective of their group belonging (HOM or
HET). The posterior cingulate cortex is regarded as one of the most critical nodes of the DMN,
whose connectivity is disrupted proportionally with global cognition not only in patients with
Alzheimer’s disease [17], but also in those with sporadic PD [18, 35]. Additionally, in patients
with both diseases, reduced connectivity between the posterior cingulate cortex and the rest of
the brain has been found since early clinical stages, preceding and perhaps contributing to local
GM atrophy [16, 17].
Beyond the MoCA assessment, HOM patients, compared to HET individuals, performed
significantly worse in tests for spatial working-memory. Consistently, HOM patients revealed a
remarkable reduction of FC also in other networks (i.e., rFP, ExN), which can be more directly
referred to working-memory [38]. In these same networks, HOM patients could be differenti-
ated not only fromHC but also fromHET individuals.We speculate that disruption of rFP
and ExN parallels the observeddisability in more specific areas of cognition. Indeed, spatial
working-memory deficits are often reported in sporadic PD, due to both a limited storage
capacity and inability to filter out distracting information [2]. Moreover, we found a direct
association between performances at Corsi test by HOM patients and the strength of FC within
ExN, SN, rFP and lFP. These networks all involve the frontoparietal cortex and overlap at both
the medial and lateral frontoparietal cortex [39]. Indeed, they are postulated to exert cognitive
functions of control [15], and their implication in working-memory is well described [39].
Beyond the role of single networks in specific cognitive functions, interactions between
them are likely to account for the appearance of complex symptoms along disease evolution, as
well as for compensation mechanisms typically observed in preclinical stages of neurodegener-
ative dementias [19]. In a recent work by Gorges and co-authors, different patterns of FC have
been reported in patients with PD according to the presence/absence of cognitive impairment
[40]. Cognitively impaired patients showed reduced FC, especially within the DMN. Con-
versely, cognitively unimpaired patients revealed a widespread increase of FC probably reflect-
ing “compensatory” mechanisms.
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We first confirmed the negative correlation reported in literature between the DMN and
other positive networks [41, 42]. In normal individuals, greater negative correlations between
the DMN and fronto-parietal networks [42] have been associated with improved performance
(and less ‘‘mind wandering”) on tasks requiring externally-directed attention. These negative
correlations suggest that the brain may be intrinsically organized to support competitive rela-
tionships between networks involved in external attention and internally focused thoughts.
When looking at group differences, we found a paradoxical positive correlation between the
DMN and SN, rFP and lPF networks in HET individuals only. This might represent a compen-
satory mechanism of early PD stages, resulting in enhanced communication between the DMN
and anterior networks. Indeed, such an effect was not observed in HOM patients. The hypothe-
sis of compensatory processes is further supported by behavioral data showing a better perfor-
mance in visual short-termworking-memory in HET individuals compared to HOM patients.
Compensatorymechanisms have already been described in asymptomatic Park2 and PINK1
mutation carriers, showing a stronger increase of corticalmotor-related activity during execu-
tion of self-initiatedmovements. These changes were interpreted as an evidence for a large-
scale reorganization of the motor system in the presymptomatic PD [6, 7].
Within the internetwork analysis, we found a strong effect which was peculiar of HOM
patients, with an increase of inter-network connectivity between SN and rFP networks. This
finding is of non-obvious interpretation, due to the lack of association with neuropsychological
data. However, we argue that such an effectmight reflect a compensation mechanism occur-
ring at more advanced disease stages, although further longitudinal studies are needed to con-
firm this interpretation.
We are aware that the present study suffers from some limitations. First, the number of sub-
jects included in the study is relatively small, due to the fact that autosomal recessive forms of
PD are relatively rare. Moreover, HOM but not HET individuals nor HC were under dopami-
nergic therapy. This could have affected the results by artificially “normalizing” FC values
within specific networks [34]. Nevertheless, we did not find any significant correlation between
functional connectivity and LEDD in HOM patients. While it is of course important to
acknowledge this potential confound, most of our findings should not be directly affected by it.
In conclusion, this study validates the use of RS-fMRI in spotting pathophysiological dys-
functions in ARPD and their relationship with cognitive impairment, especially within the
visuo-spatial working memory. Current therapies in PD primarily target the motor symptoms,
although cognitive decline is known to affect 15–20% of all patients and impact on patients’
and relatives’ quality-of-life. Altered resting-state FC in PD, reflecting clinically relevant phe-
nomena, holds promise as a marker of disease progression. Follow-up of our cohort of mutated
subjects will allow us to assess whether changes in FC can serve as a predictor for cognitive
decline, especially in HET individuals. The combination of genetic and functional neuroimag-
ing information may prove useful for monitoring individuals at risk for developing PD before
the onset of cognitive symptoms, and it is critical for planning neuro-rehabilitation programs.
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